Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Activella

(Estrogen)

ApprovedSmall molecule

This medication combines two female hormones to relieve menopausal symptoms like hot flashes and vaginal dryness by replacing the estrogen the body no longer produces. It also helps strengthen bones to prevent osteoporosis, and progestin is added to reduce the risk of uterine cancer in women who still have their uterus.[2] Activella is currently approved and in use across 21 indications[4].[1]

Activella is one of 490 small molecule programs targeting Turner syndrome. It is currently in Approved.

21

Indications

55

Total Trials

14

Active Trials

489

Competitors

Pipeline

Status by Indication[4][1]

Indication

Turner SyndromeActive, not recruiting

StrokeActive, not recruiting

Anorexia NervosaActive, not recruiting

MortalityActive, not recruiting

ArthralgiaActive, not recruiting

Stress Urinary IncontinenceActive, not recruiting

CognitionActive, not recruiting

Pelvic Organ ProlapseActive, not recruiting

Premature Ovarian InsufficiencyActive, not recruiting

AtrophyActive, not recruiting

Turner SyndromePreclinical

Active, not recruiting

StrokePhase 3

Active, not recruiting

Anorexia NervosaPhase 2

Active, not recruiting

MortalityPreclinical

Active, not recruiting

ArthralgiaPhase 2

Active, not recruiting

Stress Urinary IncontinencePreclinical

Active, not recruiting

CognitionPreclinical

Active, not recruiting

Pelvic Organ ProlapsePhase 3

Active, not recruiting

Premature Ovarian InsufficiencyPhase 3

Active, not recruiting

AtrophyPhase 3

Active, not recruiting

Showing 10 of 21 indications

Competition

Competitive Landscape

2828 competitors in Breast Cancer

#DrugCompanyPhaseTrials

Activella

Tecentriq

Trodelvy

Tykerb

Adriamycin

GGynecologic Oncology Group

Avastin

BBio-Thera Solutions

Nolvadex

SSan Diego Pacific Oncology & Hematology Associates

Prolia

Gemzar

GGynecologic Oncology Group

DATROWAY

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2027

Post-ApprovalRecruiting

Bone Health

NCT05704036

Post-ApprovalRecruiting

Overactive Bladder

NCT05221021

N/ANot yet recruiting

Stress Urinary Incontinence

NCT07186985

Q4 2027

Post-ApprovalRecruiting

Breast Cancer

NCT05562518

Q2 2028

Phase 1Recruiting

Aging

NCT06520982

Q4 2028

Phase 2Recruiting

Anorexia Nervosa

NCT03875378

Clinical

Trials by Indication[1]

Estrogen6 trials

Impact of Exogenous Estrogens on Cotisol Levels During Synacthen Stimulation

Unknown status·RRigshospitalet, Denmark·N/A·NCT05302726·20 enrolled

Estrogen Hormone Protocol

Completed·NNational Institute on Aging (NIA)·Phase 3·NCT00000177·120 enrolled

Estrogen and Serotonin on Changing Brain Chemistry

Completed·UUniversity of Colorado, Denver·N/A·NCT01208324·47 enrolled

Show 3 more trials

Postmenopausal Pessary Users: Estrogen Versus Trimosan

Terminated·TThe University of Texas Health Science Center, Houston·Phase 4·NCT03943823·4 enrolled

The Effects of Aging and Estrogen on the Pituitary

Unknown status·MMassachusetts General Hospital·Phase 2/3·NCT00386022·19 enrolled

Effect of Estrogen on Mental and Social Functioning in Girls With Turner's Syndrome

Completed·NNational Institute of Neurological Disorders and Stroke (NINDS)·N/A·NCT00004274·260 enrolled

Postmenopausal Women3 trials

Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women

Completed·NNational Heart, Lung, and Blood Institute (NHLBI)·Phase 2·NCT00001752·30 enrolled

Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to Treat OAB in Postmenopausal Women

Completed·PPeking Union Medical College Hospital·Phase 4·NCT01833663·200 enrolled

Effect of Estrogen Therapy on Objective Sleep Quality in Postmenopausal Women

Completed·—·Phase 3·NCT01501422·40 enrolled

Prostate Cancer3 trials

Transdermal Estradiol and Exercise in Mitigating Adverse Effects of Androgen Deprivation Therapy for Prostate Cancer Radiation Therapy

Not yet recruiting·—·Phase 2·NCT06271551·310 enrolled

Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle

Completed·MMemorial Sloan Kettering Cancer Center·Phase 2·NCT00586898·36 enrolled

Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial

Not yet recruiting·UUniversity of Washington·Phase 2·NCT07466498·60 enrolled

MPA2 trials

Menopausal Hormones and Sympathetic Activation

Not yet recruiting·UUniversity of Delaware·Phase 4·NCT07420218·80 enrolled

Impact of Estradiol Addback

Completed·MMayo Clinic·Phase 1·NCT01862835·43 enrolled

Cognition2 trials

Estrogen Modulation of Mood and Cognition Following Monoaminergic Depletion in Post-Menopausal Women

Unknown status·NNational Center for Research Resources (NCRR)·Phase 2·NCT00005768

The Effects of Sex Hormones on Cognition and Mood in Older Adults

Terminated·NNational Institute on Aging (NIA)·N/A·NCT00000175

34 more indications

Aging2 trials

Metabolic Effects of Androgenicity in Aging Men and Women

Completed·VVA Office of Research and Development·N/A·NCT00680797·33 enrolled

Early Neurovascular Adaptations in Aging Women

Recruiting·UUniversity of Missouri-Columbia·Phase 1·NCT06520982·64 enrolled

Menopausal Women2 trials

Buccal Estrogen in Toothpaste Study: Systemic Absorption of Estradiol When Administered Mixed With Toothpaste in Postmenopausal or Surgically Menopausal Women

Completed·NNational Center for Research Resources (NCRR)·N/A·NCT00029757·15 enrolled

Determination of Adipocyte Parameters in Iliac Crest Biopsies From Post Menopausal Women

Completed·MMayo Clinic·N/A·NCT00443716·60 enrolled

Alzheimer's Disease2 trials

Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen

Completed·UUS Department of Veterans Affairs·Phase 2·NCT00018343

Alzheimer's Disease Prevention Trial

Completed·NNational Institute on Aging (NIA)·Phase 3·NCT00000176

Depression1 trial

Estrogen and Perimenopausal Depression

Completed·UUniversity of California, Los Angeles·Phase 4·NCT00229450·17 enrolled

Memory1 trial

Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease

Completed·NNational Center for Research Resources (NCRR)·Phase 2·NCT00006399·45 enrolled

Prevention1 trial

Methenamine in a Non-antibiotic, Multimodal Approach to UTI Prevention

Withdrawn·WWashington University School of Medicine·Phase 4·NCT03996057

Pregnancy1 trial

Pregnancy Outcome of Women Using Low Molecular Weight Heparin Before Frozen-thawed Embryo Transfer

Unknown status·NNanfang Hospital, Southern Medical University·Phase 4·NCT03120715·342 enrolled

Atrophy1 trial

Evaluation of Fractional CO2 Laser Treatment Efficacy and Comparison to Vaginal Estrogen Therapy in Postmenopausal Women With Vulvovaginal Atrophy

Completed·FFaculdade de Medicina do ABC·Phase 3·NCT02419729·45 enrolled

Turner syndrome1 trial

The Effect of Androgen and Growth Hormone on Height and Learning in Girls With Turner Syndrome

Completed·TThomas Jefferson University·Phase 3·NCT00029159·200 enrolled

Function1 trial

Sex Steroids, Sleep, and Metabolic Dysfunction in Women

Completed·WWashington University School of Medicine·N/A·NCT00805207·61 enrolled

Microcirculation1 trial

Chronic Effects of Estrogen in Microcirculation

Completed·RRio de Janeiro State University·Phase 4·NCT01295892·44 enrolled

Adolescent1 trial

Bone Mass Accrual in Adolescent Athletes

Withdrawn·MMassachusetts General Hospital·Phase 3·NCT00827151

Hyaluronic Acid1 trial

Via, a Hyaluronic Acid (HLA) Based Vaginal Moisturizer Study

Not yet recruiting·NNYU Langone Health·N/A·NCT07038070·196 enrolled

Physical Therapy1 trial

Vaginal Estrogen and Pelvic Floor Physical Therapy in Women With Symptomatic Mild Prolapse

Terminated·PPamela Moalli·N/A·NCT01648751·21 enrolled

Bone Health1 trial

Estrogen Supplementation and Bone Health in Women With CF

Recruiting·JJohns Hopkins University·Phase 4·NCT05704036·75 enrolled

Chronic Pelvic Pain1 trial

A Multidisciplinary, Multimodal Bundled Care Approach to Chronic Pelvic Pain

Active, not recruiting·JJocelyn Fitzgerald·Phase 3·NCT05658874·26 enrolled

Primary Ovarian Insufficiency1 trial

Primary Ovarian Insufficiency: Phenotype and Optimal Treatment

Completed·—·Phase 3·NCT03568708·19 enrolled

Stress urinary incontinence1 trial

The Effectiveness of Combined Pelvic Floor Muscle Training and Vaginal Oestrogen Therapy in Postmenopausal Women With Stress Urinary Incontinence

Not yet recruiting·HHanoi Medical University·N/A·NCT07186985·115 enrolled

Anorexia Nervosa1 trial

Transdermal Estrogen in Women With Anorexia Nervosa

Recruiting·—·Phase 2·NCT03875378·66 enrolled

Metabolism1 trial

Regulation of Cortisol Metabolism and Fat Patterning

Unknown status·OOregon Health and Science University·N/A·NCT00694733·140 enrolled

Drug1 trial

Coronary Drug Project

Completed·NNational Heart, Lung, and Blood Institute (NHLBI)·Phase 3·NCT00000482

Menopause1 trial

Bioenergetic Effects of Aging and Menopause (BEAM)

Unknown status·UUniversity of Colorado, Denver·Phase 4·NCT04043520·57 enrolled

Pelvic Organ Prolapse1 trial

Vaginal Estrogen for Improvement of Outcomes Following Pelvic Organ Prolapse Surgery

Not yet recruiting·QQueen's University·Phase 3·NCT07030426·180 enrolled

Female1 trial

Investigation of the Effect of the Female Urinary Microbiome on Incontinence

Completed·LLoyola University·Phase 4·NCT02835846·35 enrolled

Overactive Bladder1 trial

Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome

Recruiting·WWalter Reed National Military Medical Center·Phase 4·NCT05221021·152 enrolled

Oxytocin1 trial

Dissecting the Role of Estradiol in Mediating Gender-specific Anxiolytic and Prosocial Effects of Oxytocin

Completed·UUniversity Hospital, Bonn·Phase 1·NCT04330677·487 enrolled

Breast Cancer1 trial

GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.

Recruiting·UUniversity Hospital, Ghent·Phase 4·NCT05562518·160 enrolled

Hormone Therapy1 trial

Feminizing Hormone Therapy and the Rectal Mucosa Immune Environment in Transgender Women

Completed·EEmory University··NCT04531943·285 enrolled

Mortality1 trial

Coronary Drug Project Mortality Surveillance

Completed·NNational Heart, Lung, and Blood Institute (NHLBI)·N/A·NCT00000483

Hot flashes1 trial

Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen

Completed· Eli Lilly logo

Eli Lilly·Phase 2·NCT00332553·150 enrolled

Stroke1 trial

Women's Estrogen for Stroke Trial (WEST)

Completed·NNational Institute of Neurological Disorders and Stroke (NINDS)·Phase 3·NCT00026039

Progesterone1 trial

Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism

Terminated·WWashington University School of Medicine·N/A·NCT00565916·22 enrolled

Premature ovarian insufficiency1 trial

Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency

Recruiting·EEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)·Phase 3·NCT06851754·185 enrolled

Unspecified3 trials

Clinical Study of in Situ Regeneration of Endometrium

Unknown status·YYali Hu·Phase 1/2·NCT04233892·345 enrolled

Effect of Estradiol Topical Products

Completed·UUniversity of Maryland, Baltimore·Phase 1·NCT05645393·4 enrolled

Estradiol Supplementation and Rotator Cuff Repair

Not yet recruiting·UUniversity of Utah·Phase 2·NCT06318403·58 enrolled

Sources

References

[1]
ClinicalTrials.gov — 55 trial records for Estrogen. U.S. National Library of Medicine, National Institutes of Health.
[2]
MedlinePlus Drug Information — Activella drug information. U.S. National Library of Medicine, National Institutes of Health.
[3]
ChEMBL — Estrogen compound record. European Bioinformatics Institute (EMBL-EBI).
[4]
Open Targets Platform — Drug–disease associations for Estrogen. EMBL-EBI & Wellcome Sanger Institute.
[5]
SEC EDGAR — Eli Lilly company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[3]
Highest Phase: Approved[1]
Company: Eli Lilly

Related News